
Lunai Bioworks Targets Defense Contracts and Legal Action
Lunai Bioworks is pivoting its artificial intelligence platform toward national security, securing a defense contract for chemical threat assessment while simultaneously launching a legal offensive against alleged market manipulation. CEO David Weinstein claims these dual efforts define the company's trajectory as it integrates biotechnology with government biodefense priorities.
























